Entry |
|
Name |
Piroheptine (INN) |
Formula |
C22H25N
|
Exact mass |
303.1987
|
Mol weight |
303.44
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
DG01967 Antiparkinson agent
|
Remark |
Product (DG01272): | D01231<JP> |
|
Efficacy |
Antiparkinsonian, Muscarinic acetylcholine receptor antagonist |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
DG01272 Piroheptine
D08395 Piroheptine
DG01967 Antiparkinson agent
DG01272 Piroheptine
D08395 Piroheptine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D08395 Piroheptine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
DG01272 Piroheptine
DG01967 Antiparkinson agent
DG01272 Piroheptine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C1x C 23.4500 -21.8400
2 C8y C 22.6100 -20.7200
3 C8y C 22.8900 -19.3900
4 C2y C 24.1500 -18.8300
5 C1x C 24.8500 -21.8400
6 C8y C 25.4100 -19.3900
7 C8y C 25.6900 -20.7900
8 C8x C 21.9100 -18.4100
9 C8x C 20.5800 -18.7600
10 C8x C 20.2300 -20.1600
11 C8x C 21.2100 -21.1400
12 C8x C 27.0200 -21.2100
13 C8x C 28.0700 -20.3000
14 C8x C 27.7900 -18.9000
15 C8x C 26.4600 -18.4800
16 C2y C 24.1500 -17.4300
17 C1y C 25.2700 -16.5200
18 N1y N 24.7800 -15.1900
19 C1x C 23.3100 -15.2600
20 C1x C 22.9600 -16.6600
21 C1a C 26.6000 -16.9400
22 C1b C 25.4100 -14.0000
23 C1a C 26.8100 -14.0000
BOND 26
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 7 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 6 15 2
18 4 16 2
19 16 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 16 20 1
24 17 21 1
25 18 22 1
26 22 23 1
|